Clinical outcome after progressing to frontline and second-line Anti-PD-1/PD-L1 in advanced urothelial cancer - Gomez de Liano Lista, A; van Dijk, N; de Velasco Oria de Rueda, G (Eur Urol, 2020)
et al.